• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

作为回复。

In Reply.

作者信息

de la Torre-Vallejo Martha, Turcott Jenny, Arrieta Oscar, Baracos Vickie

机构信息

Thoracic Oncology Unit/Instituto Nacional de Cancerología, Mexico City, Mexico.

Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Oncologist. 2016 Feb;21(2):e2. doi: 10.1634/theoncologist.2015-0465. Epub 2016 Jan 14.

DOI:10.1634/theoncologist.2015-0465
PMID:26768484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4746096/
Abstract

The mechanism through which sarcopenia occurs differs between cancer patients and older people. Loss of skeletal muscle mass should be considered the most clinically relevant phenotypic feature of cachexia-related sarcopenia, and it can be identified by computed tomography.

摘要

癌症患者和老年人发生肌肉减少症的机制有所不同。骨骼肌质量的丧失应被视为恶病质相关肌肉减少症最具临床相关性的表型特征，并且可以通过计算机断层扫描来识别。

相似文献

1
In Reply.作为回复。
Oncologist. 2016 Feb;21(2):e2. doi: 10.1634/theoncologist.2015-0465. Epub 2016 Jan 14.
2
Sarcopenia Is a Condition With Increasing Importance in Medical Oncology.肌肉减少症在医学肿瘤学中的重要性日益增加。
Oncologist. 2016 Feb;21(2):e1. doi: 10.1634/theoncologist.2015-0431. Epub 2016 Jan 14.
3
Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.营养状况、体表面积以及低瘦体重/体重指数与非小细胞肺癌患者中阿法替尼引起的剂量减少和严重胃肠道毒性相关。
Oncologist. 2015 Aug;20(8):967-74. doi: 10.1634/theoncologist.2015-0058. Epub 2015 Jul 14.
4
Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: results from a prospective feasibility study.
Lung Cancer. 2005 Dec;50(3):413-5. doi: 10.1016/j.lungcan.2005.07.006. Epub 2005 Sep 8.
5
[Non-small cell lung cancer: 2) Epidermal growth factor receptor inhibitor and severe adverse phenomena].
Nihon Naika Gakkai Zasshi. 2003 Jul 10;92(7):1291-5.
6
Interstitial lung disease and gefitinib.
N Engl J Med. 2010 Oct 14;363(16):1579; author reply 1579-80. doi: 10.1056/NEJMc1008506.
7
Erlotinib or gefitinib for non-small-cell lung cancer.厄洛替尼或吉非替尼用于治疗非小细胞肺癌。
N Engl J Med. 2011 Jun 16;364(24):2367; author reply 2368. doi: 10.1056/NEJMc1103918.
8
Hand-foot syndrome induced by erlotinib (Tarceva(Ⓡ) ).
Int J Dermatol. 2014 Mar;53(3):e190-2. doi: 10.1111/j.1365-4632.2012.05780.x. Epub 2013 May 15.
9
Interstitial lung disease and gefitinib.
N Engl J Med. 2010 Oct 14;363(16):1578-9; author reply 1579-80. doi: 10.1056/NEJMc1008506.
10
APL during gefitinib treatment for non-small-cell lung cancer.吉非替尼治疗非小细胞肺癌期间出现的急性早幼粒细胞白血病（APL）
N Engl J Med. 2005 Feb 24;352(8):843. doi: 10.1056/NEJM200502243520825.

本文引用的文献

1
Sarcopenia Is a Condition With Increasing Importance in Medical Oncology.肌肉减少症在医学肿瘤学中的重要性日益增加。
Oncologist. 2016 Feb;21(2):e1. doi: 10.1634/theoncologist.2015-0431. Epub 2016 Jan 14.
2
Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.营养状况、体表面积以及低瘦体重/体重指数与非小细胞肺癌患者中阿法替尼引起的剂量减少和严重胃肠道毒性相关。
Oncologist. 2015 Aug;20(8):967-74. doi: 10.1634/theoncologist.2015-0058. Epub 2015 Jul 14.
3
Measurement of skeletal muscle radiation attenuation and basis of its biological variation.骨骼肌肉放射衰减的测量及其生物学变异的基础。
Acta Physiol (Oxf). 2014 Mar;210(3):489-97. doi: 10.1111/apha.12224.
4
Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study.营养状况和血清白蛋白水平与紫杉醇-顺铂化疗治疗晚期非小细胞肺癌患者毒性发展的关系：一项前瞻性研究。
BMC Cancer. 2010 Feb 21;10:50. doi: 10.1186/1471-2407-10-50.
5
Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.非小细胞肺癌患者的身体成分：使用计算机断层扫描图像分析的癌症恶病质的现代观点。
Am J Clin Nutr. 2010 Apr;91(4):1133S-1137S. doi: 10.3945/ajcn.2010.28608C. Epub 2010 Feb 17.
6
Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".肌肉减少症、恶病质和恶病质前期的共识定义：“慢性消耗性疾病恶病质-厌食症”和“老年营养”特别兴趣小组（SIG）制定的联合文件。
Clin Nutr. 2010 Apr;29(2):154-9. doi: 10.1016/j.clnu.2009.12.004. Epub 2010 Jan 8.
7
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.一种利用常规护理期间获取的计算机断层扫描图像对癌症患者身体成分进行量化的实用且精确的方法。
Appl Physiol Nutr Metab. 2008 Oct;33(5):997-1006. doi: 10.1139/H08-075.
8
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.呼吸及胃肠道实体肿瘤患者中肌肉减少性肥胖的患病率及临床意义：一项基于人群的研究
Lancet Oncol. 2008 Jul;9(7):629-35. doi: 10.1016/S1470-2045(08)70153-0. Epub 2008 Jun 6.
9
Muscle wasting in cancer and ageing: cachexia versus sarcopenia.癌症与衰老中的肌肉消耗：恶病质与肌肉减少症
Adv Gerontol. 2006;18:39-54.